The company expects to begin trading on the CSE by July 7, provided it finalizes a US$310,000 funding agreement with Lind Global Fund III LP. This transition is part of a broader restructuring effort that includes settling $207,000 in debt through the issuance of common shares at a post-consolidated price of $0.15 each. These steps remain subject to final regulatory filings and standard listing conditions.
Else Nutrition, known for its plant-based, non-dairy infant and toddler formulas, has built its market presence on a portfolio of whole-food ingredients like buckwheat and almonds. Despite achieving significant retail traction and securing various industry accolades—including multiple Amazon best-seller rankings—the company is currently navigating the complexities of its exchange migration. Management maintains that these corporate maneuvers are essential for the next phase of its international expansion.
Comments (0)
No comments yet. Be the first!